Projeto ALFA

What Projeto ALFA does

Projeto ALFA is a private, physician-led reproductive medicine center headquartered at Rua Cincinato Braga 37, 12º andar, Bela Vista, São Paulo, Brazil. Founded in 2003 by five physicians, the clinic operates a single high-complexity assisted-reproduction laboratory staffed by 50+ multidisciplinary professionals — gynecologists, urologists, nurses, biologists, and biomedical scientists — under four named directors (Drs. Newton Eduardo Busso, Jonathas Borges Soares, Sidney Glina, and Nelson Antunes Junior). It is positioned in its own materials as a "national reference center in high-technology assisted human reproduction," with 23+ years of continuous operation, LGPD compliance, and adherence to CFM Resolution 2.168/2017 and ANVISA guidelines.

The clinic delivers the full spectrum of fertility care through its São Paulo lab, including timed intercourse (coito programado), intrauterine insemination, IVF (FIV), ICSI, PICSI, assisted hatching, cryopreservation of oocytes, sperm, embryos, ovarian and testicular tissue, alternative sperm collection (electroejaculation, TESE, TESA, PESA), and a dedicated serology-positive patient laboratory with protocols for HIV and Hepatitis B/C. Distinct sub-brands — ALFA Preserva, Eva Preserva, and ALFA Preserva Sonhos — market fertility preservation and shared egg-donation programs to women delaying maternity, oncology patients, and donor/recipient pairs. In 2025 the embryology lab adopted third-party AI tools (EMBRYOAID for embryo selection, Violet by Future Fertility for oocyte quality, and Geri+ time-lapse imaging) as part of a stated technological upgrade.

Revenue is generated on a professional-services, per-treatment basis with quote-based pricing (no public price list). The go-to-market blends direct-to-consumer acquisition through the website, WhatsApp, and an active educational blog, with a national referral network of 40+ partner specialists ("Especialistas Sugeridos") across Brazil who channel complex cases into the São Paulo lab. Customer segments are horizontal and fragmented — infertile couples, women delaying maternity, male and female oncology patients, LGBT couples, and women with ovarian failure — and educational offerings (Fellowship in Andrology, Continuous Course in Assisted Reproduction) reinforce the clinic's academic standing and talent pipeline. No external funding rounds, parent company, or acquisition activity are disclosed in the source data.

Name

Projeto ALFA

Legal name

Projeto ALFA

Website

https://projetoalfa.com.br

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Projeto ALFA is a private, physician-led fertility clinic in São Paulo, Brazil, operating a high-complexity assisted-reproduction laboratory staffed by 50+ specialists. It delivers IVF, ICSI, cryopreservation, gamete donation, and fertility preservation to infertile couples, oncology patients, women delaying maternity, and LGBT couples across Brazil.

Ownership category

akta.pro rank

Product category

Assisted Reproduction / Fertility Clinic Services

NAICS

Family Planning Centers (62141)

akta.pro industry

PRIMARYHLAFAJAD

Fertility, Reproductive Endocrinology & IVF Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAKAJAC

Reproductive Endocrinology & Infertility (IVF/Fertility)

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAKADAI

Reproductive Endocrinology & Infertility (Endocrine)

Healthcare & Life Sciences/Specialist Medical Practice/Endocrinology & Diabetes

SECONDARYHLAKAOAD

Male Reproductive & Sexual Medicine (Andrology)

Healthcare & Life Sciences/Specialist Medical Practice/Urology

Keywords

• Assisted reproduction services
• In vitro fertilization
• Fertility preservation
• Egg and embryo banking
• Male infertility treatment

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Revenue model

1. Fertility Treatments: Revenue from assisted reproduction treatments including Fertilization in Vitro (FIV), Intrauterine Insemination (IUI), programmed intercourse, ICSI, PICSI, and Assisted Hatching. Also includes alternative sperm collection procedures (electroejaculation, TESE, TESA, PESA).
2. Fertility Preservation Programs: ALFA Preserva program for egg and sperm cryopreservation, targeting women wanting to postpone motherhood and cancer patients undergoing chemotherapy/radiotherapy.
3. Egg and Embryo Bank Services: Oocyte and embryo donation/reception services under anonymous donation protocols regulated by CFM.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Core offering

Projeto ALFA is a reference center in assisted human reproduction offering the full spectrum of fertility treatments — from timed intercourse and intrauterine insemination (IUI) to in vitro fertilization (FIV), ICSI, PICSI, and assisted hatching — together with egg and embryo donation/banking, fertility preservation programs (ALFA Preserva, Eva Preserva), cryopreservation, and alternative sperm collection procedures (TESE, TESA, PESA, electroejaculation) for male factor infertility. It also operates a dedicated laboratory with special protocols for serology-positive patients (HIV, Hepatitis B and C).

Product overview

Projeto ALFA is a multidisciplinary reproductive health center offering comprehensive assisted reproduction services. The organization provides a unified portfolio of treatments including fertility treatments (FIV/ICSI, insemination, timed intercourse), gamete and embryo banking services, fertility preservation programs (ALFA Preserva, Eva Preserva), and specialized treatments for serology-positive patients. The center operates as a single integrated healthcare facility with educational programs including Fellowship in Andrology and Continuous Courses in Assisted Reproduction. The facility features high-technology laboratories with AI-powered diagnostic systems (Violet for egg quality, EMBRYOAID for embryo selection) and serves both direct patients and referring physician partners through its network of suggested specialists.

Differentiator

Problem solved

Functional benefit

Brands

• ALFA Preserva: Program of fertility preservation performed by Projeto Alfa, focused on egg and embryo cryopreservation.
• ALFA Preserva Sonhos
• Eva Preserva

Products and services

• Assisted Reproduction Treatments Range of fertility treatments including Coito Programado (timed intercourse), Inseminação Artificial (intrauterine insemination), Fertilização in Vitro FIV (IVF), ICSI, PICSI, and Assisted Hatching for couples and individuals experiencing infertility.
• Egg Bank Services (Doação e Recepção de Óvulos) Egg donation and reception services including shared donation and voluntary anonymous donation programs, regulated by CFM Resolution 2.168/2017, for patients needing donor oocytes.
• Embryo Bank Services (Doação e Recepção de Embriões) Embryo donation and reception services performed through altruistic donation of vitrified embryos from couples who have completed IVF treatment, for patients needing donor embryos.
• ALFA Preserva / Eva Preserva Fertility Preservation Program Fertility preservation program offering oocyte cryopreservation (egg freezing) for women who want to postpone motherhood or are about to undergo gonadotoxic medical treatments.
• Sperm Preservation (Gametas-Espermatozoides) Sperm freezing and preservation services for male fertility preservation, primarily for patients undergoing oncological treatments or other procedures that may compromise fertility.
• Alternative Sperm Collection Procedures Alternative sperm collection methods including Electroejaculation, Testicular Biopsy (TESE), Testicular Puncture (TESA), and Epididymal Puncture (PESA) for men with severe male factor infertility.
• Serology-Positive Patient Treatments Specialized laboratory handling of fertility treatments for patients with positive serology (HIV, Hepatitis B and C), featuring dedicated protocols including multiple sperm washing, viral load testing by PCR, and safe handling of follicular fluid and embryos.

Quantifiable outcome

• IVF success rates up to 60% for patients under 35 years, approximately 40% for ages 35-38, around 30% until 40, and 8% after 42 years
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Two partnerships are on record, tiered minor.

• ALMER - Asociación Latinoamericana de Medicina ReproductivaminorStrategic or Co-development Partner · 9 May 2019Projeto ALFA was one of the sponsors of the 2nd Annual Meeting of ALMER, on which occasion it promoted the SPIC - Simpósio Paulista de Infertilidade Conjugal (Paulista Symposium on Conjugal Infertility), which addressed the Future of Assisted Human Reproduction. The event took place on May 9, 2019, in São Paulo-SP, at Hotel Maksoud Plaza, and featured renowned specialists from various parts of the world.
• RedbitminorOthersRedbit is the web development agency responsible for creating and maintaining the Projeto ALFA website (projetoalfa.com.br) and possibly other digital assets.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Future Fertility: Vancouver-based AI company whose Violet product for oocyte quality assessment is already being used by Projeto ALFA. Comparable as an enabling AI technology provider in the reproductive medicine space and a touchpoint for understanding competitive adoption of AI in IVF labs.

Direct peers

• IVI - Instituto Valenciano de Infertilidad: Global fertility clinic chain originating in Spain with established presence in Brazil, offering the same comprehensive IVF/ICSI/egg donation service portfolio to infertile couples through a multi-clinic model. Direct competitor for Projeto ALFA's patient base and a benchmark for scale.
• Eugin: Spain-headquartered global fertility clinic chain (part of the Eugin/IVI lineage) operating across Europe and Latin America. Offers the same egg/embryo donation, IVF, and preservation services as Projeto ALFA and competes for cross-border fertility patients.
• Inception Fertility: US-based fertility network operating multiple clinic brands with full-service reproductive medicine including IVF, donor gametes, fertility preservation, and andrology services. Directly comparable in service mix, patient segments, and high-complexity lab capabilities.
• Genea Limited: Australian-headquartered global fertility clinic and technology group combining patient treatments (IVF, ICSI, fertility preservation) with proprietary lab systems. Comparable as an integrated fertility provider investing in its own lab equipment and software.
• Shady Grove Fertility (now part of Unified Women's Healthcare): Large US fertility clinic network with a comprehensive portfolio matching Projeto ALFA's: IVF/ICSI, donor egg/embryo programs, fertility preservation, and andrology. Comparable in patient-acquisition emphasis, lab quality, and reputation-driven growth.
• CCRM Fertility: Large US fertility clinic network offering IVF, ICSI, egg/embryo banking, fertility preservation, and advanced lab technologies. Comparable in service breadth and clinical specialization to Projeto ALFA, including AI-driven embryo selection and high-success-rate positioning.

Others

• CooperSurgical: Major manufacturer and distributor of fertility and reproductive medicine consumables, devices, and genetic services. Relevant as a key upstream supplier that supplies ART instruments, media, and donor gamete services to fertility clinics comparable to Projeto ALFA.
• Vitrolife: Global supplier of media, consumables, and time-lapse systems for IVF clinics (e.g., EmbryoScope). Comparable as an ecosystem supplier that defines the lab technology stack fertility clinics like Projeto ALFA deploy.
• Hamilton Thorne: Provider of precision instruments, laser systems, and time-lapse imaging for ART clinics. Comparable as an adjacent/enabling vendor whose products (and the Geri+ time-lapse incubator mentioned by Projeto ALFA) shape the technology capability set of fertility clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/alfapreserva
• Xx.com/Alfareproducao
• Facebookfacebook.com/alfareproducaohumana
• LinkedInlinkedin.com/company/projeto-alfa---alianca-de-laboratorios-de-fertilizacao-assistida

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Projeto ALFA